In brilliant news, it has been discovered that adding ribociclib to first-line endocrine therapy significantly improves both progression free and overall survival (PFS and OS) for premenopausal women with advanced breast cancer.

The Waikato Breast Cancer Research Trust (WBCRT) is seeking participants with moderately severe treatment-resistant lymphoedema for this research. Is lymphoedema of your arm an ongoing problem for you? Have you undergone at least three months of lymphoedema therapy?

Key findings announced at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago include breakthroughs in the treatment of breast cancer and research.  In a series of articles including this one, we outline some of the exciting developments reported.

Women who give so much to their families and communities now need help from the community to contribute to funding the medicines they need to treat their advanced breast cancer. These medicines help extend lives and improve quality of life.

We are thrilled that Lachlan McKenzie (38) has decided to run his first marathon for BCAC. Lachlan’s mum, Julie Bunnell, has advanced breast cancer, and Lachlan is running for BCAC because of the support we give women like her. 

Media Release of the Breast Cancer Aotearoa Coalition and Lung Foundation New Zealand

BCAC and Lung Foundation NZ media release, 

BCAC and Lung Foundation NZ media release, 30 April 2019

Health advocacy groups and individuals will present strongly worded petitions to Parliament on 7 May demanding proper funding of medicines.

Breast Cancer Aotearoa Coalition media release, 23 April 2019: PHARMAC has refused funding for Kadcyla, an important drug that has recently had a high media and public profile.

Media release:  A powerful group of women will be speaking at the Health Select Committee on 13 and 20 March to describe how traumatic it is for them to know that medicines that would give them longer live